243 related articles for article (PubMed ID: 38200568)
1. Tumor hypoxia and role of hypoxia-inducible factor in oral cancer.
Singh P; Rajput M; Pandey M
World J Surg Oncol; 2024 Jan; 22(1):18. PubMed ID: 38200568
[TBL] [Abstract][Full Text] [Related]
2. Current relevance of hypoxia in head and neck cancer.
Bredell MG; Ernst J; El-Kochairi I; Dahlem Y; Ikenberg K; Schumann DM
Oncotarget; 2016 Aug; 7(31):50781-50804. PubMed ID: 27434126
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study.
Gholami S; Chamorro-Petronacci C; Pérez-Sayáns M; Suárez Peñaranda J; Longatto-Filho A; Baltazar F; Afonso J
J Appl Oral Sci; 2023; 31():e20220461. PubMed ID: 37194791
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
6. The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma.
Choueiri TK; Fay AP; Gagnon R; Lin Y; Bahamon B; Brown V; Rosenberg JE; Hutson TE; Baker-Neblett KL; Carpenter C; Liu Y; Pandite L; Signoretti S
Clin Cancer Res; 2013 Sep; 19(18):5218-26. PubMed ID: 23881929
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of HIFs expression in head and neck cancer: a systematic review.
Gong L; Zhang W; Zhou J; Lu J; Xiong H; Shi X; Chen J
PLoS One; 2013; 8(9):e75094. PubMed ID: 24058651
[TBL] [Abstract][Full Text] [Related]
9. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
10. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
11. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
[TBL] [Abstract][Full Text] [Related]
12. ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer.
Keulers TG; Koch A; van Gisbergen MW; Barbeau LMO; Zonneveld MI; de Jong MC; Savelkouls KGM; Wanders RG; Bussink J; Melotte V; Rouschop KMA
Autophagy; 2022 Aug; 18(8):1898-1914. PubMed ID: 34904929
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
[TBL] [Abstract][Full Text] [Related]
14. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor 1alpha in oral cancer.
Brennan PA; Mackenzie N; Quintero M
J Oral Pathol Med; 2005 Aug; 34(7):385-9. PubMed ID: 16011605
[TBL] [Abstract][Full Text] [Related]
16. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
[TBL] [Abstract][Full Text] [Related]
17. Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients.
Eckert AW; Kappler M; Schubert J; Taubert H
Oral Maxillofac Surg; 2012 Jun; 16(2):189-96. PubMed ID: 22592457
[TBL] [Abstract][Full Text] [Related]
18. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
[TBL] [Abstract][Full Text] [Related]
19. Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma.
Motzer RJ; Hutson TE; Hudes GR; Figlin RA; Martini JF; English PA; Huang X; Valota O; Williams JA
Cancer Chemother Pharmacol; 2014 Oct; 74(4):739-50. PubMed ID: 25100134
[TBL] [Abstract][Full Text] [Related]
20. Novel HDGF/HIF-1α/VEGF axis in oral cancer impacts disease prognosis.
Lin YW; Huang ST; Wu JC; Chu TH; Huang SC; Lee CC; Tai MH
BMC Cancer; 2019 Nov; 19(1):1083. PubMed ID: 31711427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
